Home > Insider Trading > Filing (0001209191-16-137777)

Filing Details

Accession Number:: 0001209191-16-137777
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-18 16:38:37
Reporting Period:: 2016-08-16

Filing Date:: 2016-08-18
Accepted Time:: 2016-08-18 16:38:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624899	Steris Plc	STE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413087	Jr M Walter Rosebrough	C/O Chancery House, 190 Waterside Road Hamilton Industrial Park Leiscester X0 LE5 1QZ	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, 0.10 Nominal Value	Disposition	2016-08-16	5,000	$71.38	115,924	No	4	S	Direct
Ordinary Shares, 0.10 Nominal Value	Disposition	2016-08-16	5,000	$71.38	5,000	No	4	S	Indirect	See Footnote Below
Ordinary Shares, 0.10 Nominal Value	Disposition	2016-08-17	5,000	$70.48	0	No	4	S	Indirect	See Footnote Below

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See Footnote Below
No	4	S	Indirect	See Footnote Below

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares, 0.10 Nominal Value	68,806	Indirect	See Footnote Below.

Footnotes

This transaction involved the open market sale on August 16, 2016 of a total of 5,000 shares, held by the Reporting Person as Trustee of a revocable trust established for his benefit, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on September 1, 2015.
This represents the average sales price of the 5,000 shares sold. The actual 27 sales prices ranged from $71.07 per share to $71.70 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 27 sales prices.
These 115,924 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 44,349 of these Ordinary Shares are restricted. The restrictions on the restricted Ordinary Shares lapse as follows: 6,250 on May 31, 2017; 4,250 on May 30, 2017; 4,250 on May 30, 2018; 3,625 on May 29, 2017; 3,625 on May 28, 2018; 3,625 on May 28, 2019; 4,681 on June 1, 2017; 4,681 on June 1, 2018; 4,681 on June 3, 2019; and 4,681 on June 1, 2020.
This transaction involved the open market sale on August 16, 2016 of a total of 5,000 shares, held by the Reporting Person as Trustee, from an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse, pursuant to a Rule 10b5-1 Stock Trading Planentered into by the Reporting Person, as Trustee, effective on September 1, 2015.
This represents the average sales price of the 5,000 shares sold. The actual 30 sales prices ranged from $71.07 per share to $71.70 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 30 sales prices.
These ordinary shares are held by the Reporting Person as Trustee of an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse.
This transaction involved the open market sale on August 17, 2016 of a total of 5,000 shares, held by the Reporting Person as Trustee, from an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, effective on September 1, 2015.
This represents the average sales price of the 5,000 shares sold. The actual 26 sales prices ranged from $70.31 per share to $70.99 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 26 sales prices.
These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit.